Handbook of Stroke and Neurocritical Care. (Record no. 60474)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 09391nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3019756 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124125.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2011 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781613247983 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781613247860 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3019756 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3019756 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10671321 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)829960360 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC388.5 -- .H363 2012eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.8/1062 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Lee, Vivien H. |
| 245 10 - TITLE STATEMENT | |
| Title | Handbook of Stroke and Neurocritical Care. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2011. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (391 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Neurology - Neurology - Laboratory and Clinical Research Developments |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- HANDBOOK OF STROKE AND NEUROCRITICAL CARE -- HANDBOOK OF STROKE AND NEUROCRITICAL CARE -- Contents -- Preface -- Normal Anatomy -- Arterial Anatomy -- Great Vessels -- Carotid Arteries -- Circle of Willis (Figure 6) -- Venous Anatomy -- References -- Ischemic Stroke - Epidemiology -- References -- Ischemic Stroke-Large-Artery Atherosclerosis -- Large Artery Atherosclerosis (LAA) -- Intracranial Atherosclerotic Stenosis (ICAS) -- Carotid Atherosclerosis -- Asymptomatic Carotid Stenosis -- Symptomatic Carotid Stenosis -- Carotid Stenting Studies -- Carotid Occlusion -- Cardiac issues and Carotid Disease -- Chapter Keypoints -- References -- Small Vessel Disease Occlusion -- References -- Ischemic Stroke - Cardioembolic -- Categories of Cardioembolic Stroke -- Dysrhythmias -- Structural -- Endocarditis -- Aortic Atheroma -- References -- Ischemic Stroke- Cryptogenic -- Key Points -- Introduction -- Etiologies -- Diagnostic Tests -- Prognosis and Management -- References -- Ischemic Stroke - Other Rare Causes -- Background -- Vasculitis- Primary CNS and Systemic Diseases -- Other Inflammatory Conditions -- Infectious Causes of Stroke -- Hereditary and Genetic Conditions -- Small Vessel Hereditary Conditions -- Heritable connective tissue disorders -- Mitochondrial Disorders -- Hematologic / Prothrombotic States -- Disorders of the Arterial Wall -- References -- Textbooks -- Ischemic Stroke - Acute Therapy (IV) -- Introduction -- NIHSS Standard Images -- Scoring of NIHSS in Special Populations -- Common Mistakes when Scoring and Performing the NIHSS -- Interpreting the NIHSS -- Initial Studies -- Imaging (in the order they would be considered in most Hospitals) -- Serum Studies -- Additional Non-Neurologic Imaging Studies -- Hour Window -- Common Misconceptions about IV tPA -- So you've decided to give IV tPA… -- Consent. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Elements to include when Seeking informed Consent -- Legal Pitfalls -- Dosing/Rate -- Monitoring -- Use of tPA in Special Populations -- When good Intentions aren't enough (Protocol Violations and Impact on Outcome) -- Risk of Spontaneous Intracerebral Hemorrhage -- Drip and Ship/Telemedicine -- Future Directions in Research: Neuroprotective Therapy -- References -- Ischemic Stroke Acute Treatment Intraarterial Therapy -- References -- Ischemic Stroke in Hospital Management -- Key Points -- Non-Thrombolytic Treatment -- Blood Pressure Management in Ischemic Stroke Patients -- Stroke Units -- Prevention and Detection of Medical Complications -- Cardiac Complications -- Fevers and Infections -- Hematologic Complications -- Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE) -- GI Bleeding -- GI Complications -- Dysphagia -- Nutrition -- Hyperglycemia and Hypoglycemia -- Surgical Treatment of Ischemic Stroke -- Box Ongoing and Upcoming Clinical Trials -- References -- Ischemic Stroke- Secondary Stroke Prevention -- Anti-Platelet Medications -- Anti-Coagulants -- Surgery- Carotid Stenosis- CEA (See Chapter 3) -- Vascular Risk Factor Modification -- References -- Intracerebral Hemorrhage -- Incidence -- Etiology -- Clinical Features -- Diagnosis -- Management -- Outcomes -- Research -- References -- Subarachnoid Hemorrhage -- Epidemiology -- Risk Factors -- Diagnosis of Asah -- Clinical Features -- Imaging -- Cerebrospinal Fluid Analysis -- Conventional Four-Vessel Angiography -- Grading Scales -- Management of Asah (Figures 1 and 2) -- Control of Intracranial Pressure (ICP) -- Prevention of Re-Bleeding -- Prevention and Treatment of Delayed Cerebral Ischemia (DCI) -- Medical Complications -- Cardiopulmonary -- Hyponatremia -- Prognosis -- References -- Other Stroke Like Conditions -- Posterior Reversible Encephalopathy Syndrome (PRES). |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Reversible Cerebral Vasoconstriction Syndrome (RCVS) -- Cerebral Venous Sinus Thrombosis (CVT) -- References -- Neuroimaging -- Abbreviations -- 15.1 Introduction -- Imaging Protocols -- MR -- Stroke has 4 Main Etiologies -- 15.2 Ischemic Stroke -- 15.2.1 CT Findings in Ischemic Stroke -- NECT -- Acute Stage 0-2 Days -- Subacute Stage 2-14 Days -- Chronic Stage (Months to Year) -- CECT -- CTA -- CTP -- 15.2.2. MR Findings in Ischemic Stroke -- Conventional MR Imaging -- Acute Stage -- Subacute Stage -- Chronic Stage -- MRA -- DWI -- PWI -- Comparison of DWI and PWI Abnormalities -- 15.2.3 Strokes in Specific Vascular Distributions -- Supratentorial Infarcts -- Infratentorial Infarcts -- 15.3 Intraparenchymal Hemorrhage -- 15.3.1 Evolution of Intracranial Hemorrhage on CT -- 15.3.2 Evolution of Intracranial Hemorrhage on MR -- 15.3.3 Causes of Spontaneous Nontraumatic Intracerebral Hemorrhage -- 15.4 Nontraumatic Subarachnoid Hemorrhage -- 15.4.1 Etiologies of Nontraumatic Subarachnoid Hemorrhage -- 15.4.2 Aneurysmal Subarachnoid Hemorrhage (SAH) -- 15.4.3 Benign Perimesencephalic Hemorrhage -- 15.4.4 "Pseudo-Subarachnoid Hemorrhage" -- 15.5 Venous Infarction -- 15.5.1 Dural Sinus Thrombosis -- 15.5.2 Cortical Venous Thrombosis -- 15.5.3 Deep Cerebral Venous Thrombosis -- 15.6 Imaging Arterial Dissection -- 15.6.1 Intracranial Dissection -- 15.6.2 Extracranial Dissection -- References -- Neurosonology -- Background Physics and Principles -- Transcranial Doppler (TCD) -- Introduction -- TCD Examination Technique [1] -- Transtemporal Window -- Transorbital Window -- Transoccipital Window -- Tcd Interpretation -- TCD Clinical Applications -- Carotid Ultrasound -- References -- Cerebral Catheter Angiography -- Performing the Catheter Cerebral Angiogram -- Spinal Catheter Angiography -- References -- Pharmacology -- Intravenous Antihypertensive Agents. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Clevidipine Butyrate Injectable Emulsion (Cleviprex®) -- Nicardipine HCL Injection (Cardene®I.V.) -- Sodium Nitroprusside -- Nitroglycerin -- Labetalol HCL -- Esmolol HCL (Brevibloc®) -- Hydralazine -- Enalaprilat -- Antiplatelet Agents -- Aspirin -- Clopidogrel (Plavix) -- Abciximab (ReoPro) -- Prasugrel (Effient) -- Anticoagulants -- Dabigatran Etexilate Mesylate (Pradaxa) -- Dalteparin (Fragmin®) -- Enoxaparin (Lovenox®) -- Warfarin (Coumadin®) -- Fibrinolysis -- Tissue Plasminogen Activator (TPA)/ Alteplase (Activase®) -- Hemostatic Agents -- Coagulation Factor VIIa (Recombinant) rFVIIa (Novoseven®) -- Aminocaproic Acid (Amicar®) -- Phytonadione - Vitamin K -- Protamine Sulfate -- Hyperosmotic Agents -- Mannitol -- Hypertonic Saline -- Anticonvulsant Agents -- Carbamazepine (Tegretol®) -- Felbamate (Felbatol®) -- Fosphenytoin (Cerebryx®) -- Lacosamide (Vimpat®) -- Lamotrigine (Lamictal®) -- Levetiracetam (Keppra®) -- Pentobarbital (Nembutal®) -- Phenobarbital -- Phenytoin -- Topiramate (Topamax®) -- Valproic Acid/ Divalproex Sodium/ Valproate Sodium -- Zonisamide (Zonegran®) -- Aquaretics -- Conivaptan HCL (Vaprisol®) -- Tolvaptan (SAMSCA®) -- Acid-Inhibitors -- Miscellaneous Agents -- Nimodipine (Nimotop®) -- Antihypertensive Agents -- Thiazide Diuretics -- Loop Diuretics -- Potassium-Sparing Diuretics -- Aldosterone Receptor Blockers -- Combination Diuretics -- Beta-Blockers -- Angiotensin Converting Enzyme Inhibitors (ACE -Inhibitors) -- Angiotensin II Receptor Blockers (ARBs) -- Dihydropyridine Calcium Channel Blockers -- Non-Dihydropyridine Calcium Channel Blockers -- Alpha-Blockers -- Combined Alpha and Beta-Blockers -- Central Agonists -- Direct Vasodilators -- Cholesterol Lowering Drugs -- Ezetimibe (Zetia®) -- ICU Opioid Analgesics and ICU Sedation - See Attached Charts -- Niacin (Niaspan®) -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cerebrovascular disease -- Treatment. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neurological intensive care. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Lee, Vivien H. |
| Title | Handbook of Stroke and Neurocritical Care |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2011 |
| International Standard Book Number | 9781613247860 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Neurology - Neurology - Laboratory and Clinical Research Developments |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019756">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3019756</a> |
| Public note | Click to View |
No items available.